Sarcomelicope alkaloids as leads for the discovery of new antitumor acronycine derivatives

Phytochemistry Reviews

Volumn 1, Issue 3, 2002, Pages 355-368

  Tillequin, François ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Acridone; Acronycine; Antitumor activity; Sarcomelicope

Indexed keywords

1,2 DIACETOXY 1,2 DIHYDROACRONINE; 1,2 DIACETOXY 1,2 DIHYDROBENZO[B]ACRONINE; 1,2 DIHYDROXY 1,2 DIHYDROACRONINE DIESTER; 1,2 DIHYDROXY 1,2 DIHYDROBENZO[B]ACRONINE DIESTER; ACRONINE; CYTOTOXIC AGENT; DNA; ESTER DERIVATIVE; PLANT EXTRACT; S 23906 1; SARCOMELICOPE EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CELL PROLIFERATION; COLON CARCINOMA; CONFERENCE PAPER; CYTOTOXICITY; DNA DENATURATION; DNA HELIX; DRUG CONFORMATION; DRUG DNA BINDING; DRUG ISOLATION; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA L 1210; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TUMOR XENOGRAFT;

ACRONYCHIA; MUS MUSCULUS; RUTACEAE; SARCOMELICOPE;

EID: 3242780725     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1023/A:1026076825006     Document Type: Conference Paper

References (40)

1. Brum-Bousquet M, Mitaku S, Skaltsounis A-L, Tillequin F & Koch M (1988) Acronycine epoxide: a new acridone alkaloid from several Sarcomelicope species. Planta Med., 54: 470-471.
2. Chou T-C, Tzeng C-C, Wu T-S, Watanabe KA & Su T-L (1989) Inhibition of cell growth and macromolecule biosynthesis of human promyelocytic leukemic cells by acridone alkaloids. Phytother. Res., 3: 237-242.
3. Costes N, Michel S, Tillequin F, Koch M, Pierré A & Atassi Gh (1999) Chiral dihydroxylation of acronycine: Absolute configuration of natural cis-1,2-dihydroxy-1,2-dihydroacronycine and cytotoxicity of (1R,2R)- and (1S,2S)-1,2-diacetoxy-1,2-dihydroacronycine. J. Nat. Prod., 62: 490-492.
4. Costes N, Le Deit H, Michel S, Tillequin F, Koch M, Pfeiffer B, Renard P, Léonce S, Guilbaud N, Kraus-Berthier L, Pierré A & Atassi Gh (2000) Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3,2-h] acridin-7-one analogs of acronycine. J. Med. Chem., 43: 2395-2402.
5. Dorr RT Liddil JD (1988) Development of a parenteral formulation of the antitumour agent acronycine. J. Drug Dev., 1: 31-39.
6. Dorr RT, Liddil JD, Von Hoff DD, Soble M & Osborne CK (1989) Antitumor activity and murine pharmacokinetics of parenteral acronycine. Cancer Res., 49: 340-344.
7. Elomri A, Mitaku S, Michel S, Skaltsounis A-L, Tillequin F, Koch M, Pierré A, Guilbaud N, Léonce S, Kraus-Berthier L, Rolland Y, & Atassi Gh (1996) Synthesis and cytotoxic and antitumor activity of esters in the 1,2-dihydroxy-1,2-dihydroacronycine series. J. Med. Chem., 39: 4762-4766.
8. Fokialakis N, Mitaku S, Mikros E, Skaltsounis A-L, Tillequin F & Sévenet T (1999) Megistosarcimine and megistosarconine, two alkaloids from Sarcomelicope megistophylla. Phytochemistry, 52: 1745-1748.
9. 15N correlation at natural abundance. J. Nat. Prod., 63: 1004-1005.
10. Fokialakis N, Magiatis P, Skaltsounis A-L, Tillequin F & Sévenet T (2000b) Megistolactone, a new alkaloid from Sarcomelicope megistophylla. Z. Naturforsch., 55C: 874-876.
11. Fokialakis N, Magiatis P, Aligiannis N, Mitaku S, Tillequin F, Skaltsounis A-L & Sévenet T (2001a) Furomegistines I and II, two new alkaloids from the bark of Sarcomelicope megistophylla. Phytochemistry, 57: 593-596.
12. Fokialakis N, Magiatis P, Terzis A, Tillequin F & Skaltsounis A-L (2001b) Cyclomegistine, the first alkaloid with the new cyclobuta[b]quinoline ring system from Sarcomelicope megistophylla. Tetrahedron Lett., 42: 5323-5325.
13. Gougoutas JZ & Kaski BA (1970) The crystal and molecular structure of bromodihydroacronycine. Acta Cryst., B26: 853-859.
14. Govindachari TR, Pai BR & Subramaniam PS (1966) Alkaloids of Glycosmis pentaphylla (Retz.) Correa. Tetrahedron, 22: 3245-3252.
15. Guilbaud N, Kraus-Berthier L, Meyer-Losic F, Malivet V, Chacun C, Jan M, Tillequin F, Michel S, Koch M, Pfeiffer B, Atassi Gh, Hickman JA & Pierré A (2001) Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human tumors. Clin. Cancer Res., 7: 2573-2580.
16. Guilbaud N, Léonce S, Tillequin F, Koch M, Hickman JA & Pierré A (2002) Acronycine derivatives as promising antitumor agents. Anti-Cancer Drugs, 13: 445-449.
17. Hartley TG (1974) A revision of the genus Acronychia (Rutaceae). J. Arnold Arbor., 55: 469-567.
18. Hartley TG (1975) The taxonomic status of the genus Bauerella (Rutaceae). J. Arnold Arbor., 56: 164-170.
19. Hartley TG (1982) A revision of the genus Sarcomelicope (Rutaceae). Aust. J. Bot., 30: 359-372.
20. Hartley TG (1986) Three new species of Sarcomelicope (Rutaceae) from New Caledonia (with a new key to the species of the genus). Adansonia, 8: 183-189.
21. Hlubucek J, Ritchie E & Taylor WC (1970) A synthesis of acronycine. Aust. J. Chem., 23: 1881-1889.
22. Hughes GK Lahey FN, Price JR & Webb LJ (1948) Alkaloids of the Australian Rutaceae. Nature, 162: 223-224.
23. Léonce S, Pérez V, Lambel S, Peyroulan D, Tillequin F, Michel S, Koch M, Pfeiffer B, Atassi Gh, Hickman JA & Pierré A (2001) Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of the tumor cells in S phase leading to apoptosis. Mol. Pharmacol, 60: 1383-1391.
24. Macdonald PL & Robertson AV (1966) The structure of acronycine. Aust. J. Chem., 19: 275-281.
25. Magiatis P, Mitaku S, Skaltsounis A-L, Tillequin F, Koch M, Pierré A & Atassi Gh. (1998) Synthesis and biological activity of esters in the trans-1,2-dihydroxy-1,2-dihydroacronycine series. J. Nat. Prod., 61: 198-201.
26. Mitaku S, Skaltsounis A-L, Tillequin F, Koch M, Pusset J. & Chauvière G (1986) Alcaloïdes de Sarcomelicope glauca. J. Nat. Prod., 49: 1091-1095.
27. Mitaku S, Skaltsounis A-L, Tillequin F, Koch M, Pusset J. & Chauvière G. (1987) Four new acridone alkaloids from Sarcomelicope dogniensis Hartley (Rutaceae). Heterocycles, 26: 2057-2063.
28. Mitaku S, Skaltsounis A-L, Tillequin F, Koch M & Pusset J (1989) Alcaloïdes des écorces de Sarcomelicope dogniensis. Ann. Pharm. Fr., 47: 149-156.
29. Papageorgiou M, Fokialakis N, Skaltsounis A-L, Mitaku S, Tillequin F & Sévenet T (2000) Two new alkaloids from the bark of Sarcomelicope megistophylla. J. Nat. Prod., 63: 385-386.
30. Reisch J & Wickramasinghe A (1990) Oxidation of acridone alkaloids: Synthesis of 5-methoxyacronycine. Monatsh. Chem., 121: 709-712.
31. Reisch J & Top M (1991) Wege zum Acronycin-Epoxid und Acronycin-Diol. Pharmazie, 46: 745.
32. Reisch J & Schiwek K (1994) Synthese von Acronycinepoxid Liebigs Ann. Chem., 317-318.
33. Scarffe JH, Beaumont AR & Crowther D (1983) Phase I-II evaluation of acronycine in patients with multiple myeloma. Cancer Treat. Rep., 67: 93-94.
34. Schneider J, Evans EL, Grunberg E & Fryer RI (1972) Synthesis and biological activity of acronycine analogs. J. Med. Chem., 15: 266-270.
35. Su T-L & Watanabe KA (1993) Anticancer Acridone Alkaloids. In Studies in Natural Products Chemistry. (Vol. 13, pp. 347-382). In Rahman, A. & Basha F.Z. (Eds.). Amsterdam: Elsevier.
36. Svoboda GH (1966) Alkaloids of Acronychia baueri (Bauerella australiana) - Extraction of the alkaloids and studies of structure-activity relationships. Lloydia, 29: 206-224.
37. Svoboda GH, Poore GA, Simpson PJ & Boder GB (1966) Alkaloids of Acronychia baueri - Isolation of the alkaloids and study of the antitumor and other biological properties of acronycine. J. Pharm. Sci., 55: 758-768.
38. Tillequin F (1997) Alkaloids in the genus Sarcomelicope. Recent Res. Devel. Phytochem., 1: 675-687.
39. Tillequin F (2002) Conception de nouveaux agents antotumoraux en série acronycine. Recent Res. Devel. Ann. Pharm. Fr., 60: 246-252.
40. Tillequin F, Michel S & Skaltsounis A-L (1998) Acronycine-type Alkaloids: Chemistry and Biology. In Pelletier SW (Ed.), Alkaloids: Chemical and Biological Perspectives (Vol. 12, pp. 1-102). Oxford: Pergamon.